Qianyun Tang
Overview
Explore the profile of Qianyun Tang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
393
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng C, Chen X, Lin M, Jin Y, Guo Q, Zhou T, et al.
Acta Biomater
. 2025 Mar;
PMID: 40054648
The extracellular matrix (ECM) of solid tumor constitutes a formidable physical barrier that impedes immune cell infiltration, contributing to immunotherapy resistance. Breast cancer, particularly triple-negative breast cancer (TNBC), is characterized...
2.
Lu X, Jin P, Tang Q, Zhou M, Xu H, Su C, et al.
Adv Sci (Weinh)
. 2025 Feb;
:e2412109.
PMID: 39988985
Cervical cancer (CC) is a major health threat to women, with immunotherapies targeting the programmed death receptor 1/programmed death ligand 1(PD-1/PD-L1) axis showing promise but encountering resistance in a significant...
3.
Zhang S, Wang X, Chen X, Shu D, Lin Q, Zou H, et al.
Adv Mater
. 2025 Jan;
37(9):e2409378.
PMID: 39840472
Hypoxia severely limits the antitumor immunotherapy for breast cancer. Although efforts to alleviate tumor hypoxia and drug delivery using diverse nanostructures achieve promising results, the creation of a versatile controllable...
4.
Shan J, Du L, Wang X, Zhang S, Li Y, Xue S, et al.
Adv Sci (Weinh)
. 2024 Apr;
11(20):e2304441.
PMID: 38576170
The inflammatory damage caused by thrombus formation and dissolution can increase the risk of thrombotic complications on top of cell death and organ dysfunction caused by thrombus itself. Therefore, a...
5.
Liang P, Tang Q, Cai Y, Liu G, Si W, Shao J, et al.
Chem Sci
. 2023 Sep;
14(37):10363.
PMID: 37772114
[This corrects the article DOI: 10.1039/C7SC03351F.].
6.
Lv Z, Huang M, Yang J, Li P, Chang L, Tang Q, et al.
Adv Mater
. 2023 Jul;
35(36):e2300823.
PMID: 37461803
Messenger RNA (mRNA) transfection is the prerequisite for the application of mRNA-based therapeutics. In hard-to-transfect cells, such as macrophages, the effective transfection of mRNA remains a long-standing challenge. Herein, a...
7.
Liang P, Shao J, Tang Q, Si W, Wang Q, Zhang Q, et al.
RSC Adv
. 2023 Jun;
13(26):17621.
PMID: 37313001
[This corrects the article DOI: 10.1039/C7RA06551E.].
8.
Li F, Li J, Yang W, Yang S, Chen C, Du L, et al.
Angew Chem Int Ed Engl
. 2023 Jun;
62(32):e202305536.
PMID: 37278518
The trans-cleavage property of CRISPR-Cas12a system makes it an excellent tool for disease diagnosis. Nevertheless, most methods based on CRISPR-Cas system still require pre-amplification of the target to achieve the...
9.
Cai Y, Liang P, Tang Q, Si W, Chen P, Zhang Q, et al.
ACS Appl Mater Interfaces
. 2023 May;
15(21):26225.
PMID: 37198920
No abstract available.
10.
Cai Y, Liang P, Tang Q, Yang X, Si W, Huang W, et al.
ACS Nano
. 2023 May;
17(11):11072.
PMID: 37196144
No abstract available.